3Sourris KC, Morley AL, Koitka A, et al. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the an- giotensin II type 2 ( AT2 ) receptor [ J ]. Diabetologia, 2010, 53(11) :2 442 -2 451.
4Yamagishi S, Matsui T. Advanced glycation end products, oxi- dative stress and diabetic nephropathy [ J ]. Oxid Med Cell Longer,2010,3(2) :101 - 108.
5Das Evcimen N, King GL. The role of protein kinase C acti- vation and the vascular complications of diabetes [ J ]. Phar- macol Res,2007,55 (6) :498 - 510.
6Navarro-Gonzalez JF, Mora-Femandez C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the patho- genesis of diabetic nephropathy [ J ]. Nat Rev Nephrol,2011, 7(6) :327 -340.
7Taniguchi K,Xia L, Goldberg HJ,et al. Inhibition of Src kinase blocks high glucose-induced EGFR transactivation and collagen synthesis in mesangial cells and prevents diabetic nephropathy in mice[J]. Diabetes,2013,62( 11 ) :3 874 -3 886.
8Loeffler I, Raster C, Franke S, et al. Erythropoietin amelio- rates podocyte injury in advanced diabetic nephropathy in the db/db mouse [ J]. Am J Physiol Renal Physiol, 2013, 305(6) :1;911 -918.
9Tian S, Tang J, Liu H, et al. Propyl gallate plays a nephro- protective role in early stage of diabetic nephropathy associ- ated with suppression of glomerular endothelial cell prolifer- ation and angiogenesis [ J]. Exp Diabetes Res,2012,2012 : 209 567.
10Ruster C, Wolf G. The role of chemokines and ehemokine receptors in diabetic nephropathy [ J ]. Front Biosci, 2008, 13:944 -955.
6Fecher LA,Amaravadi RK,Flaherty KT.The MAPK pathway in melanoma.Curr Opin Oncol,2008,20(2):183-189.
7Faour WH,Thibodeau JF,Kennedy CR.Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes.Cell Signal,2010,22(8):1222-1230.
8Dai T,Natarajan R,Nast CC,et al.Glucose and diabetes:effects on podocyte and glomerular p38MAPK,heat shock protein 25,and actin cytoskeleton.Kidney Int,2006,69(5):806-814.
9Rose BA,Force T,Wang Y.Mitogen-activated protein kinase signaling in the heart:angels versus demons in a heart-breaking tale.Physiol Rev,2010,90(4):1507-1546.
10Suzaki Y,Yoshizumi M,Kagami S,et al.BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions.Kidney Int,2004,65(5):1749-1760.
8Rehman J,Monga M,Landman J,et a1.Characterization of intrapelvic pressure during ureteropyeloscopy with ureteral access sheaths.Urology,2013;61 (4)∶713~718.
